NV-Clindamycin 150 mg Capsule is a Health Canada–registered veterinary drug (DIN 02245832) held by Teva Canada Limited, containing Clindamycin (Clindamycin Hydrochloride). Health Canada lists its status as Marketed (status date 30 Jul 2014). Nexara Health has matched 825 registrations of Clindamycin (Clindamycin Hydrochloride) across 32 other regulated markets, 52 of them in the same strength and dosage form.
Health Canada registration
| DIN | 02245832 |
|---|---|
| Brand name | NV-Clindamycin |
| Active ingredient | Clindamycin (Clindamycin Hydrochloride) |
| Strength | 150 mg |
| Dosage form | Capsule |
| Route | Oral |
| Company | Teva Canada Limited |
| Status | Marketed — 30 Jul 2014 |
| Class | Veterinary |
| ATC | |
| AHFS | |
| Regulator record | Health Canada DPD entry · Product monograph |
Clindamycin (Clindamycin Hydrochloride) registered in other markets
825 registrations of the same molecule in 32 national registries outside Canada (first 120 shown, exact strength and form first). Each row is taken from the regulator's own published list; status is shown as the registry reports it.
| Country | Product | Marketing authorisation holder | Strength | Form | Status | Registry |
|---|---|---|---|---|---|---|
| Austria | Dalacin C 150 mg Kaps. | — | 16St | green box | eEKO (Erstattungskodex) | |
| Bahrain | Clindacin | United Pharmaceutical Manufacturing Co. Ltd, Jordan. | 150 MG | Capsule | POM | NHRA |
| Bahrain | Dalacin-C | Pfizer Holding France, France. | 150 MG | Capsule | POM | NHRA |
| Bahrain | Qcin | Renata Limited, Bangladesh. | 150 MG | Hard Capsule | POM | NHRA |
| Bulgaria | Clindamycin ABR | Антибиотик - Разград АД | 150mg capsules, hard | капсула, твърда | По лекарско предписание | BDA |
| Bulgaria | Dalacin C | Pfizer Europe MA EEIG | 150 mg hard capsules | твърди капсули | По лекарско предписание | BDA |
| Czech Republic | Dalacin C | — | 150MG | Cps Dur | R | SUKL DLP |
| Denmark | Antirobe Vet. | Zoetis Animal Health ApS | 150 mg | kapsler, hårde | National | Laegemiddelstyrelsen |
| Denmark | Clinacin Vet. | Chanelle Pharmaceuticals Manufacturing Limited | 150 mg | kapsler, hårde | MRP | Laegemiddelstyrelsen |
| Denmark | Clindamycin "Alternova" | Alternova A/S | 150 mg | kapsler, hårde | MRP | Laegemiddelstyrelsen |
| Denmark | Dalacin | Pfizer ApS | 150 mg | kapsler, hårde | National | Laegemiddelstyrelsen |
| Denmark | Dalacin C | Orifarm A/S | 150 mg | kapsler, hårde | Par-Imp | Laegemiddelstyrelsen |
| Ireland | Clindamycin 150 mg Capsules, hard | Renata Pharmaceuticals (Ireland) Limited | Capsule, hard | Marketed | HPRA | |
| Ireland | Dalacin C 150 mg Hard Capsules | IMED Healthcare Ltd., | Capsule, hard | Unknown | HPRA | |
| Ireland | Dalacin C 150 mg Hard Capsules | Pfizer Healthcare Ireland Unlimited Company | Capsule, hard | Marketed | HPRA | |
| Ireland | Dalacin C 150 mg Hard Capsules | PCO Manufacturing Ltd. | Capsule, hard | Unknown | HPRA | |
| Ireland | Dalacin C 150 mg Hard Capsules | Merit Pharmaceuticals Limited | Capsule, hard | Unknown | HPRA | |
| Italy | DALACIN C*12 cps 150 mg | PFIZER ITALIA Srl | CLINDAMICINA 150MG 12 UNITA' USO ORALE | Classe A | AIFA liste A/H | |
| Malta | Dalacin 150 mg hard capsules | JV Healthcare Limited | Hard Capsule | Authorised | Medicines Authority | |
| Malta | Dalacin 150mg hard capsules | Cherubino Limited | Hard Capsule | Authorised | Medicines Authority | |
| Malta | Dalacin C 150 mg Hard Capsules | Pfizer Hellas S.A. | Hard Capsule | Authorised | Medicines Authority | |
| Malta | DALACIN C 150 mg hard capsules | Pharma Regulatory Services Limited | Hard Capsule | Authorised | Medicines Authority | |
| Norway | Dalacin kaps 150 mg | Pfizer AS | 40 x 1 | Kapsel, hard | Aktiv oppføring | FEST (DMP) |
| Poland | Dalacin C | Pfizer Europe MA EEIG | 150 mg | Kapsułki | Bezterminowe | URPL RPL |
| Romania | DALACIN C 150 mg | — | 150mg | Caps. | PRF | ANMDMR nomenclator |
| Saudi Arabia | Dalacin C 150 mg Caps | — | 150 | Inactive | SFDA | |
| Saudi Arabia | Dalacin-C 150 mg Caps | — | 150 | Inactive | SFDA | |
| Singapore | CLIMADAN CAPSULE 150 mg | Zyfas Pharma Pte Ltd | 150 mg | Capsule | Prescription Only | HSA |
| Singapore | DALACIN C CAPSULE 150 mg | Pfizer Private Limited | 150 mg | Capsule | Prescription Only | HSA |
| Singapore | Novell-Clindamycin Capsule 150 mg | Goldplus Universal Pte Ltd | 150mg | Capsule | Prescription Only | HSA |
| Singapore | Qcin Capsule 150 mg | Sea Pharma Consultancy Pte Ltd | 150 mg | Capsule | Prescription Only | HSA |
| Singapore | TIDACT CAPSULE 150 mg | Yung Shin Pharmaceutical (Singapore) Pte Ltd | 150 mg | Capsule | Prescription Only | HSA |
| Sweden | Clindamycin Bijon | UAB BIJON medica | 150 mg | Kapsel | PV | TLV periodens varor |
| Sweden | Clindamycin Bijon | UAB BIJON medica | 150 mg | Kapsel | PV | TLV periodens varor |
| Sweden | Clindamycin Bijon | UAB BIJON medica | 150 mg | Kapsel | R1 | TLV periodens varor |
| Sweden | Clindamycin EQL Pharma | EQL Pharma AB | 150 mg | Kapsel | Nej | TLV periodens varor |
| Sweden | Clindamycin EQL Pharma | EQL Pharma AB | 150 mg | Kapsel | Nej | TLV periodens varor |
| Sweden | Clindamycin Orifarm | Orifarm Generics AB | 150 mg | Kapsel | PV | TLV periodens varor |
| Sweden | Clindamycin Orifarm | Orifarm Generics AB | 150 mg | Kapsel | R1 | TLV periodens varor |
| Sweden | Clindamycin Orifarm | Orifarm Generics AB | 150 mg | Kapsel | R1 | TLV periodens varor |
| Taiwan | B.b. Cap. 150mg (Clindamycin) | 瑞士藥廠股份有限公司新市廠 | 膠囊劑 | Registered | TFDA | |
| Taiwan | Bibi-U Capsules 150mg | 瑞士藥廠股份有限公司新市廠 | 膠囊劑 | Registered | TFDA | |
| Taiwan | Cledomycin Capsules 150mg "Astar" (Clindamycin) | 安星製藥股份有限公司 | 膠囊劑 | Registered | TFDA | |
| Taiwan | Cleocin Capsules 150mg | Pfizer Manufacturing Belgium NV | 膠囊劑 | 已註銷 | TFDA | |
| Taiwan | Cleocin HCl Capsules 150mg (Clindamycin HCl Hydrate) | 普強股份有限公司 | 膠囊劑 | 已註銷 | TFDA | |
| Taiwan | Clincin Cap. 150mg (Clindamycin) "N.k." | 南光化學製藥股份有限公司 | 膠囊劑 | 已註銷 | TFDA | |
| Taiwan | Clincin Capsules 150mg "Taiwan Tung Yang" (Clindamycin) | 瑞士藥廠股份有限公司新市廠 | 膠囊劑 | 已註銷 | TFDA | |
| Taiwan | Clindamycin Capsule 150mg "Patron" | 臺灣派頓化學製藥股份有限公司 | 膠囊劑 | Registered | TFDA | |
| Turkey | Cleocin 150 mg 16 Kapsul | Pfi̇zer Pfe İlaçlari Anoni̇m Şi̇rketi̇ | Aktif | TITCK | ||
| Turkey | Clin 150 mg 16 Kapsul | Menari̇ni̇ Sağlik Ve İlaç Sanayi̇ Ti̇caret Anoni̇m Şi̇rketi̇ | Aktif | TITCK | ||
| Turkey | Klindan 150 mg 16 Kapsul | Bi̇li̇m İlaç Sanayi̇i̇ Ve Ti̇caret A.ş. | Aktif | TITCK | ||
| United Kingdom | Clindamycin 150mg capsules | — | 0001 | NHS dm+d VMP | ||
| Argentina | Clidan | Cassarß | gel dérm.x 15 g | Listed | PAMI | |
| Argentina | Clidan 300 | Cassarß | cáps. x 16 | Listed | PAMI | |
| Argentina | Clindacin | Panalab | gel x 50 g | Listed | PAMI | |
| Argentina | Clindacin | Panalab | sol.x 50 ml | Listed | PAMI | |
| Argentina | Clindalaf | Lafedar | 300 mg cáps.x 16 | Listed | PAMI | |
| Argentina | Clindamicina Fabra | Fabra | 600 mg a.x 1 | Listed | PAMI | |
| Argentina | Clindamicina Richet | Richet | 300 mg cáps.x 16 | Listed | PAMI | |
| Argentina | Clintopic | Siegfried | loc.x 30 ml | Listed | PAMI | |
| Australia | Clindamyk | Af | Capsule 150 mg (as hydrochloride) | GE | PBS | |
| Australia | Dalacin C | Pf | Capsule 150 mg (as hydrochloride) | GE | PBS | |
| Austria | Clienzo 10 mg/g + 50 mg/g Gel | — | 30g | green box | eEKO (Erstattungskodex) | |
| Austria | Clindac "Sandoz" 300 mg Kaps. | — | 16St | green box | eEKO (Erstattungskodex) | |
| Austria | Clindac "Sandoz" 450 mg Filmtabl. | — | 12St | green box | eEKO (Erstattungskodex) | |
| Austria | Clindac "Sandoz" 450 mg Filmtabl. | — | 30St | green box | eEKO (Erstattungskodex) | |
| Austria | Clindac "Sandoz" 600 mg Filmtabl. | — | 30St | green box | eEKO (Erstattungskodex) | |
| Austria | Clindac "Sandoz" 600 mg Filmtabl. | — | 12St | green box | eEKO (Erstattungskodex) | |
| Austria | Clindamycin "1A Pharma" 300 mg Kaps. | — | 16St | green box | eEKO (Erstattungskodex) | |
| Bahrain | Avocin | Middle East Pharmaceutical Industries Co. Ltd (Avalon Pharma), Ksa. | 1 %W/V | Topical Solution | POM | NHRA |
| Bahrain | Avocin | Middle East Pharmaceutical Industries Co. Ltd (Avalon Pharma), Ksa. | 2 %W/W | Vaginal Cream | POM | NHRA |
| Bahrain | Clindacin | United Pharmaceutical Manufacturing Co. Ltd, Jordan. | 300 MG | Capsule | POM | NHRA |
| Bahrain | Clindacin | United Pharmaceutical Manufacturing Co. Ltd, Jordan. | 1 % W/W | Gel | POM | NHRA |
| Bahrain | Clindacin T | United Pharmaceutical Manufacturing Co. Ltd, Jordan. | 10 MG/ML | Cutaneous Solution | POM | NHRA |
| Bolivia | Clindamicina | — | 75 mg/5 ml | Suspensión o Jarabe | R | LINAME (formulary) |
| Bolivia | Clindamicina | — | 300 mg | Comprimido | R | LINAME (formulary) |
| Bolivia | Clindamicina | — | 600 mg | Inyectable | LINAME (formulary) | |
| Bulgaria | Clindamycin ABR | Антибиотик - Разград АД | 600 mg capsules, hard | капсула, твърда | По лекарско предписание | BDA |
| Bulgaria | Clindamycin ABR | Антибиотик - Разград АД | 300 mg capsules, hard | капсула, твърда | По лекарско предписание | BDA |
| Bulgaria | Clindamycin Kabi | Fresenius Kabi d.o.o. | 150 mg/ml solution for injection | инжекционен разтвор | По лекарско предписание | BDA |
| Bulgaria | Clindamycin-MIP | MIP Pharma GmbH | 600 mg film - coated tablets | филмирани таблетки | По лекарско предписание | BDA |
| Bulgaria | Clindamycin-MIP | MIP Pharma GmbH | 150 mg/ml solution for injection | инжекционен разтвор | По лекарско предписание | BDA |
| Bulgaria | Clindamycin-MIP | MIP Pharma GmbH | 300 mg film - coated tablets | филмирани таблетки | По лекарско предписание | BDA |
| Czech Republic | Clindamycin Hameln | — | 150MG/ML | Inj/Inf Sol | R | SUKL DLP |
| Czech Republic | Clindamycin Kabi | — | 150MG/ML | Inj Sol/Inf Cnc Sol | R | SUKL DLP |
| Czech Republic | Clindamycin Noridem | — | 150MG/ML | Inj/Inf Sol | R | SUKL DLP |
| Czech Republic | Dalacin | — | 20MG/G | Vag Crm | R | SUKL DLP |
| Czech Republic | Dalacin C | — | 150MG/ML | Inj/Inf Sol | R | SUKL DLP |
| Czech Republic | Dalacin C | — | 300MG | Cps Dur | R | SUKL DLP |
| Czech Republic | Duac | GlaxoSmithKline, s.r.o. | 10MG/G+50MG/G | Gel | B | SUKL DLP |
| Denmark | Antirobe Vet. | Zoetis Animal Health ApS | 25 mg | kapsler, hårde | National | Laegemiddelstyrelsen |
| Denmark | Antirobe Vet. | Zoetis Animal Health ApS | 75 mg | kapsler, hårde | National | Laegemiddelstyrelsen |
| Denmark | Antirobe Vet. | Zoetis Animal Health ApS | 300 mg | kapsler, hårde | National | Laegemiddelstyrelsen |
| Dominican Republic | Clavel | Laboratorios Cymacla, S.r.l. | Registered | MISPAS | ||
| Dominican Republic | Clidets | Stiefel Mexicana,S.a De C.v, De Mexico | Registered | MISPAS | ||
| Dominican Republic | Clinda D 300 | Laboratorios Ameripharma, S.r.l | Registered | MISPAS | ||
| Dominican Republic | Clinda D 600 mg | Laboratorios Ameripharma, S.r.l | Registered | MISPAS | ||
| Dominican Republic | Clindabiotic® 300 | Grob Pharma Corp | Registered | MISPAS | ||
| Dominican Republic | Clindacin 1% | Panalab S.a., Argentina | Registered | MISPAS | ||
| Dominican Republic | Clindamicina | M/S East African (India) Overseas | Registered | MISPAS | ||
| Dominican Republic | Clindamicina | Laboratorio San Luis, S.a | Registered | MISPAS | ||
| Ecuador | CLINDAMICINA 100 mg ÓVULOS | Kronos Laboratorios C. Ltda | CLINDAMICINA FOSFATO 118 mg (EQUIVALENTE A 100 mg DE CLINDAMICINA) | Óvulos | VIGENTE | ARCSA registro sanitario |
| Ecuador | Clindamicina 100mg + Ketoconazol 400mg Óvulos Inpharchem | Farmayala Pharmaceutical Company S.a. Fpc | Clindamicina 100mg Ketoconazol 400mg | Ovulos Vaginales | VIGENTE | ARCSA registro sanitario |
| Ecuador | Clindamicina 150 mg/ mL Solución Inyectable | Caplin Point Laboratories Ltd. | 150 mg/mL | Solucion Inyectable | VIGENTE | ARCSA registro sanitario |
| Ecuador | Clindamicina 150 mg/mL | Hiral Labs Limited | Clindamicina fosfato equivalente a Clindamicina.................................150 mg | Solucion Inyectable | VIGENTE | ARCSA registro sanitario |
| Ecuador | CLINDAMICINA 150 mg/mL | Pharmabrand S.a. | Clindamicina 600.00 mg/ 4 mL | Solucion Inyectable | VIGENTE | ARCSA registro sanitario |
| Ecuador | CLINDAMICINA 300 mg CÁPSULAS | Caplin Point Laboratories Ltd. | CLINDAMICINA 300 mg | Capsulas | VIGENTE | ARCSA registro sanitario |
| Ecuador | Clindamicina 300 mg. Capsulas | Genfar S.a. | Clindamicina Clorhidrato USP 78% B.H....................................... 384.62000 mg equivalente a Clindamicina base ............................................... 300.00000 mg | Capsulas | VIGENTE | ARCSA registro sanitario |
| Ecuador | Clindamicina 300mg Tabletas Recubiertas Inpharchem | Farmayala Pharmaceutical Company S.a. | Clindamicina 300mg | Tabletas Recubiertas | VIGENTE | ARCSA registro sanitario |
| Greece | ACNATAC GEL.EXT.US (10+0.25) MG/G TUBx30 g | Viatris Healthcare Limited, Ireland | reimbursed | MoH deltio timwn | ||
| Greece | Cleo-Fort® Vag.sup 100mg/Supp Bt X 3 Σε Ταινια Απο Pvc/Pe | Nassington Ltd, Cyprus | reimbursed | MoH deltio timwn | ||
| Greece | CLIDACIN® BA FREE INJ.SO.INF 300MG/2ML AMP BTx1 AMPx2 ML | Βιανεξ Α.ε. Ανωνυμος Εμποροβιομηχανικη-Τουριστικη-Ξενοδοχειακη Και Ναυτιλιακη Ανωνυμος Εταιρεια Δ.τ. Βιανεξ Α.ε. | reimbursed | MoH deltio timwn | ||
| Greece | CLIDACIN® BA FREE INJ.SO.INF 600MG/4ML AMP BTx1AMPx4ML | Βιανεξ Α.ε. Ανωνυμος Εμποροβιομηχανικη-Τουριστικη-Ξενοδοχειακη Και Ναυτιλιακη Ανωνυμος Εταιρεια Δ.τ. Βιανεξ Α.ε. | reimbursed | MoH deltio timwn | ||
| Greece | Climycen Vag.cr 2% Tubx40g+7appl. | Help Α.β.ε.ε. Ανωνυμη Βιομηχανικη Και Εμπορικη Εταιρεια Φαρμακευτικων Και Νοσοκομειακων Ειδων Δ.τ. Help Α.β.ε.ε./Help S.a. , Ελλαδα | reimbursed | MoH deltio timwn | ||
| Greece | Clindamycin/Anfarm Inj.so.inf 150mg/mL Bt X 1 Amp (Glass-Type I) X 2ml | Ανφαρμ Ελλας Α.ε. | reimbursed | MoH deltio timwn | ||
| Greece | Clindamycin/Anfarm Inj.so.inf 150mg/mL Bt X 1 Amp (Glass-Type I) X 4ml | Ανφαρμ Ελλας Α.ε. | reimbursed | MoH deltio timwn | ||
| Greece | Clindamycin/Anfarm Inj.so.inf 150mg/mL Bt X 10 Amps (Glass-Type I) X 2ml | Ανφαρμ Ελλας Α.ε. | reimbursed | MoH deltio timwn | ||
| Iceland | Antirobe vet | Icepharma - óskráð | 75 mg | töflur | 0 | Lyfjastofnun lyfjaverdskra |
| Iceland | Antirobe vet | Icepharma - óskráð | 300 mg | töflur | 0 | Lyfjastofnun lyfjaverdskra |
| Iceland | Antirobe vet | Icepharma - óskráð | 25 mg | töflur | 0 | Lyfjastofnun lyfjaverdskra |
See every manufacturer of Clindamycin (Clindamycin Hydrochloride) worldwide →
Regulator price references for Clindamycin (Clindamycin Hydrochloride)
Published list or reimbursement prices for Clindamycin (Clindamycin Hydrochloride) presentations, in local currency, as at the date each registry last published. These are public reference prices, not Nexara Health quotes; strength and pack differ by row.
| Country | Product | Strength | Pack | Price | Type | Source | As of |
|---|---|---|---|---|---|---|---|
| Austria | Dalacin C 150 mg Kaps. | 150mg | 16St | 6.40 EUR | KVP (Kassenverkaufspreis) | eEKO (Erstattungskodex) | 2026-09-03 |
| Bahrain | Clindacin | 150mg | 16 | 1.52 BHD | retail (max) | NHRA | 2026-09-01 |
| Bahrain | Dalacin-C | 150mg | 16 | 1.78 BHD | retail (max) | NHRA | 2026-09-01 |
| Bahrain | Qcin | 150mg | 24 | 2.65 BHD | retail (max) | NHRA | 2026-09-01 |
| Australia | Dalacin C | Capsule 150 mg (as hydrochloride) | 4.00 AUD | ex-manufacturer | PBS | 2026-09-08 | |
| Australia | Clindamycin LU | Capsule 150 mg (as hydrochloride) | 4.00 AUD | ex-manufacturer | PBS | 2026-09-08 | |
| Austria | Dalacin Vaginalcreme | 20000mg | 20g | 8.75 EUR | KVP (Kassenverkaufspreis) | eEKO (Erstattungskodex) | 2026-09-03 |
| Austria | Clindac "Sandoz" 600 mg Filmtabl. | 600mg | 12St | 10.20 EUR | KVP (Kassenverkaufspreis) | eEKO (Erstattungskodex) | 2026-09-03 |
| Austria | Clindamycin "1A Pharma" 450 mg Filmtabl. | 450mg | 12St | 10.20 EUR | KVP (Kassenverkaufspreis) | eEKO (Erstattungskodex) | 2026-09-03 |
| Austria | Clindamycin "1A Pharma" 600 mg Filmtabl. | 600mg | 12St | 10.20 EUR | KVP (Kassenverkaufspreis) | eEKO (Erstattungskodex) | 2026-09-03 |
| Austria | Clindac "Sandoz" 450 mg Filmtabl. | 450mg | 12St | 10.20 EUR | KVP (Kassenverkaufspreis) | eEKO (Erstattungskodex) | 2026-09-03 |
| Austria | Dalacin C 300 mg Kaps. | 300mg | 16St | 10.45 EUR | KVP (Kassenverkaufspreis) | eEKO (Erstattungskodex) | 2026-09-03 |
| Austria | Clindamycin-MIP 300 mg Filmtabl. | 300mg | 16St | 10.45 EUR | KVP (Kassenverkaufspreis) | eEKO (Erstattungskodex) | 2026-09-03 |
| Austria | Clindamycin-MIP 600 mg Filmtabl. | 600mg | 16St | 13.30 EUR | KVP (Kassenverkaufspreis) | eEKO (Erstattungskodex) | 2026-09-03 |
| Austria | Clindac "Sandoz" 300 mg Kaps. | 300mg | 16St | 13.55 EUR | KVP (Kassenverkaufspreis) | eEKO (Erstattungskodex) | 2026-09-03 |
| Austria | Clindamycin "1A Pharma" 300 mg Kaps. | 300mg | 16St | 13.55 EUR | KVP (Kassenverkaufspreis) | eEKO (Erstattungskodex) | 2026-09-03 |
| Austria | Clienzo 10 mg/g + 50 mg/g Gel | 30000mg | 30g | 15.80 EUR | KVP (Kassenverkaufspreis) | eEKO (Erstattungskodex) | 2026-09-03 |
| Austria | Clindac "Sandoz" 600 mg Filmtabl. | 600mg | 30St | 20.55 EUR | KVP (Kassenverkaufspreis) | eEKO (Erstattungskodex) | 2026-09-03 |
| Austria | Clindamycin "1A Pharma" 450 mg Filmtabl. | 450mg | 30St | 20.55 EUR | KVP (Kassenverkaufspreis) | eEKO (Erstattungskodex) | 2026-09-03 |
| Austria | Clindamycin "1A Pharma" 600 mg Filmtabl. | 600mg | 30St | 20.55 EUR | KVP (Kassenverkaufspreis) | eEKO (Erstattungskodex) | 2026-09-03 |
| Austria | Clindac "Sandoz" 450 mg Filmtabl. | 450mg | 30St | 20.55 EUR | KVP (Kassenverkaufspreis) | eEKO (Erstattungskodex) | 2026-09-03 |
| Austria | Clindamycin-MIP 600 mg Filmtabl. | 600mg | 32St | 21.55 EUR | KVP (Kassenverkaufspreis) | eEKO (Erstattungskodex) | 2026-09-03 |
| Bahrain | Avocin | 30ML | 1.43 BHD | retail (max) | NHRA | 2026-09-01 | |
| Bahrain | Dalacin-C | 300mg/2ml | 2ML | 1.43 BHD | retail (max) | NHRA | 2026-09-01 |
| Bahrain | Medacin T | 1pct | 30ML | 1.47 BHD | retail (max) | NHRA | 2026-09-01 |
| Bahrain | Derma-T | 30ML | 1.63 BHD | retail (max) | NHRA | 2026-09-01 | |
| Bahrain | Clindacin | 1pct | 30G | 1.78 BHD | retail (max) | NHRA | 2026-09-01 |
| Bahrain | Clindacin | 300mg | 16 | 2.49 BHD | retail (max) | NHRA | 2026-09-01 |
| Bahrain | Clindacin T | 10mg/1ml | 50ML | 2.73 BHD | retail (max) | NHRA | 2026-09-01 |
| Bahrain | Dalacin-C | 300mg | 16 | 3.23 BHD | retail (max) | NHRA | 2026-09-01 |
| Bahrain | Qcin | 300mg | 30 | 4.03 BHD | retail (max) | NHRA | 2026-09-01 |
| Bahrain | Avocin | 40G | 6.11 BHD | retail (max) | NHRA | 2026-09-01 | |
| Bahrain | Dalacin | 100mg | 3 | 7.07 BHD | retail (max) | NHRA | 2026-09-01 |
| Bahrain | Yenlip | 100mg | 7 | 10.69 BHD | retail (max) | NHRA | 2026-09-01 |
| Greece | Clindamycin/Anfarm Inj.so.inf 150mg/mL Bt X 1 Amp (Glass-Type I) X 2ml | 150mg/1ml | 0.66 EUR | producer price (ex-factory) | MoH deltio timwn | 2026-09-03 | |
| Greece | CLIDACIN® BA FREE INJ.SO.INF 300MG/2ML AMP BTx1 AMPx2 ML | 300mg/2ml | 0.68 EUR | producer price (ex-factory) | MoH deltio timwn | 2026-09-03 | |
| Greece | CLINDAMYCIN/TARGET CUT.SOL 1% FLx30ML | 1pct+30ml | 1.32 EUR | producer price (ex-factory) | MoH deltio timwn | 2026-09-03 | |
| Greece | Clindamycin/Demo So.inj.inf 150mg/mL Bt X 1 Φυσιγγα Χ 4ml | 150mg/1ml | 1.33 EUR | producer price (ex-factory) | MoH deltio timwn | 2026-09-03 | |
| Greece | Clindamycin/Anfarm Inj.so.inf 150mg/mL Bt X 1 Amp (Glass-Type I) X 4ml | 150mg/1ml | 1.33 EUR | producer price (ex-factory) | MoH deltio timwn | 2026-09-03 | |
| Greece | VELDOM INJ.SO.INF 150MG/1ML BTx1AMPx4ML (600MG) | 150mg/1ml | 1.33 EUR | producer price (ex-factory) | MoH deltio timwn | 2026-09-03 | |
| Greece | EDASON INJ.SOL 600MG/4ML AMP BTx1 AMP x 4 ML | 600mg/4ml | 1.33 EUR | producer price (ex-factory) | MoH deltio timwn | 2026-09-03 | |
| Greece | CLIDACIN® BA FREE INJ.SO.INF 600MG/4ML AMP BTx1AMPx4ML | 600mg/4ml | 1.33 EUR | producer price (ex-factory) | MoH deltio timwn | 2026-09-03 | |
| Greece | TOLIKEN CUT.SOL 1% (W/V) FLx30 ML | 1pct+30ml | 1.61 EUR | producer price (ex-factory) | MoH deltio timwn | 2026-09-03 | |
| Greece | YGIELLE CUT.SOL 1% W/V FL x 30 ML | 1pct+30ml | 1.61 EUR | producer price (ex-factory) | MoH deltio timwn | 2026-09-03 | |
| Greece | DALACIN C INJ.SOL 600MG/4ML AMP BTx1AMPx4ML | 600mg/4ml | 2.04 EUR | producer price (ex-factory) | MoH deltio timwn | 2026-09-03 | |
| Greece | DALACIN C GEL.EXT.US 1% (W/W) TUBx30G | 1pct+30000mg | 3.10 EUR | producer price (ex-factory) | MoH deltio timwn | 2026-09-03 | |
| Greece | DALACIN C CAPS 300MG/CAP ΒΤx16(BLIST 2x8) | 300mg | 3.22 EUR | producer price (ex-factory) | MoH deltio timwn | 2026-09-03 | |
| Greece | ESTERIA VAG.CR 2% W/W BT x 1 TUB x 40 G+ 7 δοσιμετρικοί εφαρμοστές 7 δοσιμετρικοί εφαρμοστές | 2pct+40000mg | 4.56 EUR | producer price (ex-factory) | MoH deltio timwn | 2026-09-03 | |
| Greece | Fouch Vag.cr 2% Tubx40g+7 Appl | 2pct+40000mg | 4.56 EUR | producer price (ex-factory) | MoH deltio timwn | 2026-09-03 | |
| Greece | YGIELLE VAG.CR 2% W/W TBx40 G+7 APPL. | 2pct+40000mg | 4.56 EUR | producer price (ex-factory) | MoH deltio timwn | 2026-09-03 | |
| Greece | Velkaderm Vag.cr 2% Tubx40g+7appl | 2pct+40000mg | 4.56 EUR | producer price (ex-factory) | MoH deltio timwn | 2026-09-03 | |
| Greece | VELDOM VAG.CR 2% W/W BT x TUB x 40G+7 δοσομετρικοί εφαρμοστές δοσομετρικοί εφαρμοστές | 2pct+40000mg | 4.56 EUR | producer price (ex-factory) | MoH deltio timwn | 2026-09-03 | |
| Greece | UPDERM VAG.CR 2% (W/W) TUBx40 G+7 Δοσιμετρικοί εφαρμοστές Δοσιμετρικοί εφαρμοστές | 2pct+40000mg | 4.56 EUR | producer price (ex-factory) | MoH deltio timwn | 2026-09-03 | |
| Greece | VAGICLIN VAG.CR 2% W/W TUBx40G+7APPL | 2pct+40000mg | 4.56 EUR | producer price (ex-factory) | MoH deltio timwn | 2026-09-03 | |
| Greece | Climycen Vag.cr 2% Tubx40g+7appl. | 2pct+40000mg | 4.56 EUR | producer price (ex-factory) | MoH deltio timwn | 2026-09-03 | |
| Greece | CLINDAMYCIN/COOPER INJ.SO.INF 600MG/4ML BTx5 amp x4ML | 600mg/4ml | 6.63 EUR | producer price (ex-factory) | MoH deltio timwn | 2026-09-03 | |
| Greece | Clindamycin/Anfarm Inj.so.inf 150mg/mL Bt X 10 Amps (Glass-Type I) X 2ml | 150mg/1ml | 6.63 EUR | producer price (ex-factory) | MoH deltio timwn | 2026-09-03 | |
| Greece | Clindamycin/Demo So.inj.inf 150mg/mL Bt X 5 Φυσιγγες Χ 4ml | 150mg/1ml | 6.63 EUR | producer price (ex-factory) | MoH deltio timwn | 2026-09-03 | |
| Greece | DALACIN C VAG.CR 2% (W/W) TUB x 40G (7 δοσομετρικοί εφαρμοστές) (7 δοσομετρικοί εφαρμοστές) | 2pct+40000mg | 7.02 EUR | producer price (ex-factory) | MoH deltio timwn | 2026-09-03 | |
| Greece | Cleo-Fort® Vag.sup 100mg/Supp Bt X 3 Σε Ταινια Απο Pvc/Pe | 100mg | 7.69 EUR | producer price (ex-factory) | MoH deltio timwn | 2026-09-03 | |
| Greece | CLINDAMYCIN/KABI INJ.SOL 150MG/ML BT x 5 AMPS x 4 ML | 150mg/1ml | 8.11 EUR | producer price (ex-factory) | MoH deltio timwn | 2026-09-03 | |
| Greece | YENLIP VAG.SUP 100MG/SUP BTx7 (1 STRIP x7 SUP) | 100mg | 10.45 EUR | producer price (ex-factory) | MoH deltio timwn | 2026-09-03 | |
| Greece | INDOXYL GEL.EXT.US (1+5)% W/W TUB x 30 G | 30000mg | 11.63 EUR | producer price (ex-factory) | MoH deltio timwn | 2026-09-03 | |
| Greece | ACNATAC GEL.EXT.US (10+0.25) MG/G TUBx30 g | 30000mg | 12.90 EUR | producer price (ex-factory) | MoH deltio timwn | 2026-09-03 | |
| Greece | INDOXYL GEL.EXT.US (1+3)% W/W 1 TUB x 30g (σωληνάριο Glaminate) | 30000mg | 12.90 EUR | producer price (ex-factory) | MoH deltio timwn | 2026-09-03 | |
| Greece | Clindamycin/Anfarm Inj.so.inf 150mg/mL Bt X 10 Amps (Glass-Type I) X 4ml | 150mg/1ml | 13.26 EUR | producer price (ex-factory) | MoH deltio timwn | 2026-09-03 | |
| Greece | TRETICLIN GEL.EXT.US (1+0.025)% w/w BTx1 TUBx50G | 50000mg | 16.22 EUR | producer price (ex-factory) | MoH deltio timwn | 2026-09-03 | |
| Greece | INDOXYL GEL.EXT.US (1+5)% W/W TUB x 60 G | 60000mg | 21.17 EUR | producer price (ex-factory) | MoH deltio timwn | 2026-09-03 | |
| Iceland | Dalacin | 150mg/1ml | lykja | 763.00 ISK | max wholesale | Lyfjastofnun lyfjaverdskra | 2026-09-02 |
| Iceland | Dalacin | 150mg/1ml | lykja | 1,398.00 ISK | max wholesale | Lyfjastofnun lyfjaverdskra | 2026-09-02 |
| Iceland | Clindamycin EQL Pharma | 150mg | þpakki | 1,500.00 ISK | max wholesale | Lyfjastofnun lyfjaverdskra | 2026-09-02 |
| Iceland | Dalacin | 20mg/1000mg | sett | 1,598.00 ISK | max wholesale | Lyfjastofnun lyfjaverdskra | 2026-09-02 |
| Iceland | Dalacin | 300mg | þpakki | 1,689.00 ISK | max wholesale | Lyfjastofnun lyfjaverdskra | 2026-09-02 |
| Iceland | Dalacin | 10mg/1ml | glas | 1,844.00 ISK | max wholesale | Lyfjastofnun lyfjaverdskra | 2026-09-02 |
| Iceland | Clindamycin EQL Pharma | 300mg | þpakki | 2,011.00 ISK | max wholesale | Lyfjastofnun lyfjaverdskra | 2026-09-02 |
| Iceland | Duac | 60mg/1000mg | túpa | 3,236.00 ISK | max wholesale | Lyfjastofnun lyfjaverdskra | 2026-09-02 |
| United Arab Emirates | Derma-T ® | 1000mg/100ml | 30ml Bottle + Applicator | 22.00 AED | public | EDE | 2026-08-31 |
| United Arab Emirates | DALACIN C ™ 300mg | 300mg | 16's (8's Blister x 2) | 33.00 AED | public | EDE | 2026-08-31 |
| United Arab Emirates | Medacin T | 10mg/1000mg | 30g Collapsible Tube | 39.00 AED | public | EDE | 2026-08-31 |
| United Arab Emirates | Dalacin ® Vaginal Ovule | 100mg | 3's Strip | 77.00 AED | public | EDE | 2026-08-31 |
Marketed Canadian products with the same active ingredient
| DIN | Product | Company | Strength | Form |
|---|---|---|---|---|
| 02436914 | Auro-Clindamycin | Auro Pharma Inc | 300 mg | Capsule |
| 02436906 | Auro-Clindamycin | Auro Pharma Inc | 150 mg | Capsule |
| 02400537 | Clindamycin | Sanis Health Inc | 300 mg | Capsule |
| 02400529 | Clindamycin | Sanis Health Inc | 150 mg | Capsule |
| 02230540 | Clindamycin Injection USP | Sandoz Canada Incorporated | 150 mg | Liquid |
| 02230535 | Clindamycin Injection USP | Sandoz Canada Incorporated | 150 mg | Solution |
| 02462664 | Med-Clindamycin | Generic Medical Partners Inc | 300 mg | Capsule |
| 02462656 | Med-Clindamycin | Generic Medical Partners Inc | 150 mg | Capsule |
| 02493748 | Nra-Clindamycin | Nora Pharma Inc | 150 mg | Capsule |
| 02493756 | Nra-Clindamycin | Nora Pharma Inc | 300 mg | Capsule |
| 02468484 | Riva-Clindamycin | Laboratoire Riva Inc. | 300 mg | Capsule |
| 02241709 | Teva-Clindamycin | Teva Canada Limited | 150 mg | Capsule |
Sourcing through Nexara Health
Nexara Health is a Health Canada–licensed wholesaler (DEL #3-002896) in Winnipeg. Because this DIN is marketed in Canada, supply normally comes through the Canadian channel; where the Canadian presentation is short or discontinued, the registrations above show which regulated markets hold an equivalent that can be imported under the Special Access Programme or for clinical comparator use. Request a quote or read how named-patient and foreign-pack supply works in Canada.
Frequently asked questions
Is NV-Clindamycin (DIN 02245832) marketed in Canada?
Yes. Health Canada lists DIN 02245832 as Marketed as of 30 Jul 2014.
Who holds the Canadian licence for this product?
Teva Canada Limited is the company of record in the Health Canada Drug Product Database.
Is Clindamycin (Clindamycin Hydrochloride) registered outside Canada?
Yes — Nexara Health has matched 825 registrations in 32 other markets, including 52 in the same strength and dosage form (see the table above).
Where does this data come from?
Health Canada Drug Product Database (DPD), DIN 02245832, status date 2014-07-30; national medicine registries: AIFA liste A/H, ANMDMR nomenclator, ARCSA registro sanitario, BDA, eEKO (Erstattungskodex), FEST (DMP), HPRA, HSA, Laegemiddelstyrelsen, LINAME (formulary), Lyfjastofnun lyfjaverdskra, Medicines Authority, MISPAS, MoH deltio timwn, NHRA, NHS dm+d VMP, PAMI, PBS, SFDA, SUKL DLP, TFDA, TITCK, TLV periodens varor, URPL RPL; price sources: EDE, eEKO (Erstattungskodex), Lyfjastofnun lyfjaverdskra, MoH deltio timwn, NHRA, PBS. Nexara Health re-checks these sources weekly and shows the last verification date at the top of the page.
Source: Health Canada Drug Product Database (DPD), DIN 02245832, status date 2014-07-30; national medicine registries: AIFA liste A/H, ANMDMR nomenclator, ARCSA registro sanitario, BDA, eEKO (Erstattungskodex), FEST (DMP), HPRA, HSA, Laegemiddelstyrelsen, LINAME (formulary), Lyfjastofnun lyfjaverdskra, Medicines Authority, MISPAS, MoH deltio timwn, NHRA, NHS dm+d VMP, PAMI, PBS, SFDA, SUKL DLP, TFDA, TITCK, TLV periodens varor, URPL RPL; price sources: EDE, eEKO (Erstattungskodex), Lyfjastofnun lyfjaverdskra, MoH deltio timwn, NHRA, PBS.
Teva Canada Limited — company profileWho else makes Clindamycin (Clindamycin Hydrochloride)All Canadian Clindamycin (Clindamycin Hydrochloride) productsAuro-ClindamycinAuro-ClindamycinClindamycinClindamycinClindamycin Injection USP
Health Canada Drug Product Database (DPD), DIN 02245832, status date 2014-07-30; national medicine registries: AIFA liste A/H, ANMDMR nomenclator, ARCSA registro sanitario, BDA, eEKO (Erstattungskodex), FEST (DMP), HPRA, HSA, Laegemiddelstyrelsen, LINAME (formulary), Lyfjastofnun lyfjaverdskra, Medicines Authority, MISPAS, MoH deltio timwn, NHRA, NHS dm+d VMP, PAMI, PBS, SFDA, SUKL DLP, TFDA, TITCK, TLV periodens varor, URPL RPL; price sources: EDE, eEKO (Erstattungskodex), Lyfjastofnun lyfjaverdskra, MoH deltio timwn, NHRA, PBS. Last reviewed 2026-09-16. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.